INS and diabetes mellitus: This is because of the unavailability, or high cost, of diagnostic tests and diabetes monitoring, including HbA1c, glucose-lowering drugs, and insulin, as well as poorly trained medical doctors and paramedics, and poor compliance with the therapy and follow-up.